Search results
Lack of insurance may prevent Americans from accessing best cancer drugs
United Press International via Yahoo News· 21 hours agoA cutting-edge class of drugs is saving and extending the lives of cancer patients. But the drugs,...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 23 hours agoThe treatment, called Krazati, was little better than standard chemotherapy in a study enrolling about 300 patients with advanced non-small cell lung cancer, according to ...
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes
Reuters· 2 days ago, opens new tab immunotherapies Opdivo and Yervoy prior to surgery for patients whose skin cancer...
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe decision follows a US Food and Drug Administration (FDA) approval for the Opdivo combination...
ASCO24: Tagrisso in the spotlight, Caribou’s adjustment and Lilly’s KRAS competitor
BioPharma Dive via Yahoo Finance· 23 hours agoAstraZeneca’s targeted therapy could see wider use after ASCO data. Elsewhere, Caribou sought to...
Bristol Myers (BMY) Gets EC Nod for Opdivo Label Expansion
Zacks via Yahoo Finance· 5 days agoBristol Myers' (BMY) Opdivo combination regimen receives the European Commission's approval for the...
Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID
Digital Journal· 1 day ago(NASDAQ: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases. Aethlon Medical, Inc. (NASDAQ: AEMD) ...
Why US Drug Giant Bristol Myers Squibb Stock Trading Up On Monday - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 21 hours agoAt a median follow-up of 9.4 months, Krazati demonstrated a statistically significant and clinically...
ASCO: Early Purple data gain ground in metastatic pancreatic cancer
FierceBiotech· 3 days agoPurple Biotech hopes its lead asset against metastatic pancreatic cancer will one day show its true...
Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents
MedPage Today· 3 days agoChina-based trial may present a hurdle to FDA approval, however